Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Celgene discovers new isotopologues of lenalidomide

Sep. 1, 2010

Phase II and III trials examine SIR-Spheres in patients with refractory colorectal liver metastases

Sep. 1, 2010

Yissum claims new MMP-2 inhibitors

Sep. 1, 2010

Patient recruitment begins for phase II MK-2206 trial in colorectal cancer

Aug. 31, 2010

FDA extends review of eribulin NDA for advanced or metastatic breast cancer

Aug. 31, 2010

Genentech describes selection of novel Chk1 inhibitor for further development

Aug. 31, 2010

Tasigna approved in Switzerland for Ph+ chronic myeloid leukemia

Aug. 30, 2010

SuperGen discovers new inhibitors of tyrosine-protein kinase receptor UFO

Aug. 27, 2010

Cellceutix moves toward human trials of Kevetrin for drug-resistant cancer

Aug. 26, 2010

New hepatocyte growth factor receptor inhibitors claimed by sanofi-aventis

Aug. 26, 2010

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld
Parkinson’s disease is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder, and...
First-in-class pan-inflammasome blocker for hidradenitis suppurativa
BioWorld Science
Researchers from Paratus Sciences Corp. presented the preclinical profile of PS-1001, a novel pan-inflammasome inhibitor designed to prevent IL-1β and IL-18 release.
RX-10616 improves radiotherapy efficacy in HNSCC
BioWorld Science
Head and neck squamous cell carcinoma (HNSCC) accounts for high number of new diagnoses each year. Current management is based on surgery followed by radiotherapy...
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...